Ventas (VTR) Stock Forecast: StockMap's 2-Week Call
VTR stock forecast: StockMap's model leans Outperform on Ventas for the two weeks after the Nov 13 close, toward VTR doing better than the growth index. It is a lean inside the no-call band, not a call, and not a price target. Too few two-week windows graded to judge yet.
Ventas last closed at $88.92, -0.81% on the session.
Against the IVW growth benchmark the position is +0.10% over the forecast window.
Ventas' market cap is $47.02B as of November 13, 2026, #250 in the S&P 500.
Leans up ↗: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 27 (too close to call).
Where VTR sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 11 bullish and 4 bearish.
Agreement across those insights is 73%.
12 daily calls for VTR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Ventas in the 2nd percentile on valuation and the 42nd percentile on return on equity, where 100 is best.
Ventas is classified under Real Estate / Health Care REITs.
StockMap tracks Ventas as the 2nd largest of the 17 companies it covers in the Health Care REITs industry, part of the Real Estate sector.
Across that group the current two-week reads are 9 Neutral, 6 Moderate Underperform and 2 Moderate Outperform.
On that composite Ventas ranks 2nd of 17 in the group, against a group median of -0.18.